Losing Weight and Triglycerides: A Case of Tirzepatide Use in a Patient with Familial Chylomicronemia Syndrome
Presented by: Linda Liu, M.D.
Learning Objectives:
- Describe familial chylomicronemia syndrome (FCS) diagnosis, pathophysiology, and management.
- Identify notable considerations in weight loss management for patients with lipid disorder.
- Discuss use of tirzepatide and other GLP1 receptor agonists in patients with lipid disorders.
AND
“Obesity, Hypertension, and Kidney Disease.”
Presented by: Silvana Pannain, M.D.
Learning Objectives:
- Case-Based Understanding of Obesity Pathophysiology: Gain an in-depth understanding of the underlying pathophysiology of the relationship between obesity, HTN and Kidney disease through the analysis and discussion of clinical cases.
- Enhance participants' knowledge in iatrogenic weight gain in HTN and the effect of weight loss in HTN and Kidney disease.
- Enhance participants' knowledge and skills in the utilization of antiobesity medications in HTN and Kidney disease.
Session date:
05/09/2024 - 7:00am to 8:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Drs. Linda Liu and Silvana Pannain